Axillary lymphadenopathy in a renal cell carcinoma patient after COVID-19 Vaccination.
Radiol Case Rep
; 16(8): 2164-2167, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1267897
ABSTRACT
The distribution of the novel Covid-19 vaccines has been on a scale as unprecedented as the pandemic itself. While the vaccines promise to greatly reduce the spread and impact of the disease, encountering side-effects in clinical practice may pose diagnostic dilemmas. In this case report, we describe a patient with known metastatic renal cell carcinoma who presents with axillary lymphadenopathy found on PET/CT imaging after receiving a Covid-19 vaccine, which was subsequently confirmed to be reactive lymphadenopathy following biopsy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Radiol Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
J.radcr.2021.05.031
Similar
MEDLINE
...
LILACS
LIS